The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's current revenue (TTM ) is A$53.21 Billion. an increase over the revenue in the year 2023 that were of A$41.37 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | A$53.73 B | 29.87% |
2023 | A$41.37 B | 6.97% |
2022 | A$38.68 B | 7.95% |
2021 | A$35.83 B | 8.38% |
2020 | A$33.06 B | -0.91% |
2019 | A$33.36 B | -1.01% |
2018 | A$33.70 B | 15.18% |
2017 | A$29.26 B | -8.24% |
2016 | A$31.89 B | 7.26% |
2015 | A$29.73 B | 21.29% |
2014 | A$24.51 B | 17.09% |
2013 | A$20.93 B | 26.03% |
2012 | A$16.61 B | 9.32% |
2011 | A$15.19 B | 2.55% |
2010 | A$14.81 B | -9.08% |
2009 | A$16.29 B | -23.35% |
2008 | A$21.26 B | 25.87% |
2007 | A$16.89 B | -6.66% |
2006 | A$18.09 B | 6.55% |
2005 | A$16.98 B | 24.61% |
2004 | A$13.63 B | 21.28% |
2003 | A$11.24 B | 16.36% |
2002 | A$9.66 B | 24.56% |
2001 | A$7.75 B | 24.23% |
2000 | A$6.24 B | 28.04% |
1999 | A$4.87 B | 12.99% |
1998 | A$4.31 B | 19.86% |
1997 | A$3.60 B | 30.12% |
1996 | A$2.76 B |